Bibliografisk träff 2024-01-30 Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist. Glen A, Bürli RW, Livermore D, Buffham W, Merison S, Rowland AE, Newman R, Fieldhouse C, Miller DJ, Dawson LA, Matthews K, Carlton MB, Brice NL. Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2024.129629